The Impact of Obesity on Left Ventricular Hypertrophy and Diastolic Function in Caucasian Children

Delia Mercea1, Raluca Ianos1, Călin Pop1

  • 1Emergency County Hospital "Dr Constantin Opris", Baia Mare, Romania.

Insights

Childhood obesity is linked to left ventricular hypertrophy (LVH), a thickening of the heart muscle. However, early signs of diastolic dysfunction were not found in obese children compared to normal-weight peers.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Health
  • Obesity Research

Background:

  • Left ventricular hypertrophy (LVH) and diastolic dysfunction are known complications of obesity and hypertension in adults.
  • Limited research exists on the direct impact of childhood obesity on left ventricular function.
  • This study addresses the gap by investigating obesity's effect on pediatric cardiac structure and function.

Purpose of the Study:

  • To evaluate the impact of obesity and LVH on left ventricular diastolic function in children.
  • To compare cardiac function in pediatric subjects with and without obesity.
  • To identify early cardiac changes associated with childhood obesity.

Main Methods:

  • Prospective study of 454 pediatric patients (33 obese, 20 overweight, 401 normal weight).
  • Standardized two-dimensional echocardiography to assess interventricular septum thickness, posterior wall thickness, and left atrium size.
  • Analysis of left ventricular diastolic function using pulsed-wave Doppler, tissue Doppler, and continuous Doppler techniques.

Main Results:

  • Obese children showed significantly increased interventricular septum and posterior wall thickness (LVH) compared to non-obese children (P < 0.001).
  • Left ventricular systolic function remained preserved in both obese and non-obese groups.
  • No significant early alterations in left ventricular diastolic function were detected in obese children.

Conclusions:

  • Childhood obesity is associated with significant myocardial structural changes, specifically LVH.
  • Despite LVH, early diastolic dysfunction was not observed in obese children in this cohort.
  • Further research is needed to understand long-term cardiac implications of obesity-related LVH in pediatric populations.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
176
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
301
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
171
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
685
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
186
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
133